SofWave Medical Ltd. (SOFW.TA)
ILA 1616.0
(2.73%)
ILA 1616.0
(2.73%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -6.61 Million USD | 61.04% |
| 2022 | -16.97 Million USD | -99.79% |
| 2021 | -8.49 Million USD | -29.01% |
| 2020 | -11.32 Million USD | -99.73% |
| 2019 | -3.19 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -251 Thousand USD | -592.16% |
| 2024 Q2 | -655 Thousand USD | -160.96% |
| 2023 Q4 | 51 Thousand USD | 105.8% |
| 2023 FY | - USD | 61.04% |
| 2023 Q3 | -879 Thousand USD | 59.12% |
| 2023 Q2 | -2.15 Million USD | 33.11% |
| 2023 Q1 | -3.21 Million USD | -7.26% |
| 2022 Q2 | -4.48 Million USD | -5.9% |
| 2022 Q1 | -4.23 Million USD | -28.11% |
| 2022 FY | - USD | -99.79% |
| 2022 Q4 | -2.99 Million USD | 37.68% |
| 2022 Q3 | -4.8 Million USD | -7.27% |
| 2021 Q1 | -1.13 Million USD | 39.14% |
| 2021 FY | - USD | -29.01% |
| 2021 Q3 | -3.3 Million USD | -191.83% |
| 2021 Q4 | -3.3 Million USD | 0.0% |
| 2021 Q2 | -1.13 Million USD | 0.0% |
| 2020 FY | - USD | -99.73% |
| 2020 Q4 | -1.86 Million USD | 0.0% |
| 2020 Q3 | -1.86 Million USD | -33.0% |
| 2020 Q2 | -1.39 Million USD | 0.0% |
| 2020 Q1 | -1.39 Million USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|